Core Viewpoint - The company is adapting to a changing market environment and competitive landscape by focusing on technology-driven strategies and increasing investment in research and innovation to enhance profitability [1] Group 1: Strategic Focus - The company will concentrate on the development of new veterinary drugs to provide high-quality and cost-effective animal health products and solutions for the aquaculture industry, thereby improving the efficiency of its clients' farming operations [1] - The company aims to deepen its "raw material-formulation integration" strategy to ensure stable raw material supply and controllable costs, which will enhance competitive barriers and increase product market competitiveness [1] Group 2: Business Expansion - The company is accelerating its layout in the pet medicine sector by leveraging its advantages in research and innovation to enrich its product matrix and complete the pet business segment, creating a new growth driver [1] - The company is implementing an "outbound" strategy to actively explore overseas markets, which will help mitigate the cyclical impacts on domestic business [1]

Core Insights - The company is adapting to a changing market environment and competitive landscape by deepening its "raw material-formulation integration" strategy, which is expected to stabilize raw material supply and control costs, thereby enhancing product competitiveness [2] Group 1 - The company is facing a continuously evolving market environment and competitive dynamics [2] - The "raw material-formulation integration" strategy is aimed at ensuring stable raw material supply and cost control [2] - This strategy is expected to raise competitive barriers and enhance product market competitiveness [2]